Novel CYP1B1-RMDN2 Alzheimer’s disease locus identified by genome-wide association analysis of cerebral tau deposition on PET

Kwangsik Nho, Shannon L. Risacher, Liana Apostolova, Paula J. Bice, Jared Brosch, Rachael Deardorff, Kelley Faber, Martin R. Farlow, Tatiana Foroud, Sujuan Gao, Thea Rosewood, Jun Pyo Kim, Kelly Nudelman, Paul Aisen, Reisa Sperling, Basavaraj Hooli, Sergey Shcherbinin, Diana Svaldi, Clifford R. Jack, William J. Jagust, Susan Landau, Aparna Vasanthakumar, Jeffrey F. Waring, Vincent Doré, Simon M. Laws, Colin L. Masters, Tenielle Porter, Christopher C. Rowe, Victor L Villemagne, Logan Dumitrescu, Timothy J. Hohman, Julia B. Libby, Elizabeth Mormino, Rachel F. Buckley, Keith Johnson, Hyun-Sik Yang, Ronald C. Petersen, Vijay K. Ramanan, Prashanthi Vemuri, Ann D. Cohen, Kang-Hsien Fan, M. Ilyas Kamboh, Oscar L. Lopez, David A. Bennett, Muhammad Ali, Tammie Benzinger, Carlos Cruchaga, Diana Hobbs, Philip L. De Jager, Masashi Fujita, Vaishnavi Jadhav, Bruce T. Lamb, Andy P. Tsai, Isabel Castanho, Jonathan Mill, Michael W. Weiner, the Alzheimer’s Disease Neuroimaging Initiative (ADNI), the Alzheimer’s Disease Neuroimaging Initiative – Department of Defense, the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Study (A4 Study), the Australian Imaging, Biomarker & Lifestyle Study (AIBL), Andrew J. Saykin
doi: https://doi.org/10.1101/2023.02.27.23286048

Article Information

doi 
https://doi.org/10.1101/2023.02.27.23286048
History 
  • March 1, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Kwangsik Nho1,2,3,4,*,
  2. Shannon L. Risacher1,3,*,
  3. Liana Apostolova1,3,5,6,
  4. Paula J. Bice1,3,
  5. Jared Brosch3,5,
  6. Rachael Deardorff3,5,
  7. Kelley Faber6,7,
  8. Martin R. Farlow3,5,
  9. Tatiana Foroud3,6,7,
  10. Sujuan Gao3,8,
  11. Thea Rosewood1,2,3,
  12. Jun Pyo Kim1,2,3,
  13. Kelly Nudelman3,6,7,
  14. Paul Aisen9,
  15. Reisa Sperling10,
  16. Basavaraj Hooli11,
  17. Sergey Shcherbinin11,
  18. Diana Svaldi11,
  19. Clifford R. Jack12,
  20. William J. Jagust13,
  21. Susan Landau13,
  22. Aparna Vasanthakumar14,
  23. Jeffrey F. Waring14,
  24. Vincent Doré15,16,
  25. Simon M. Laws17,
  26. Colin L. Masters18,
  27. Tenielle Porter17,
  28. Christopher C. Rowe16,
  29. Victor L Villemagne16,19,
  30. Logan Dumitrescu20,
  31. Timothy J. Hohman20,21,
  32. Julia B. Libby20,
  33. Elizabeth Mormino22,
  34. Rachel F. Buckley10,
  35. Keith Johnson10,23,
  36. Hyun-Sik Yang10,24,
  37. Ronald C. Petersen25,
  38. Vijay K. Ramanan25,
  39. Prashanthi Vemuri12,
  40. Ann D. Cohen19,
  41. Kang-Hsien Fan26,
  42. M. Ilyas Kamboh26,
  43. Oscar L. Lopez19,27,
  44. David A. Bennett28,
  45. Muhammad Ali29,
  46. Tammie Benzinger30,
  47. Carlos Cruchaga29,31,
  48. Diana Hobbs30,
  49. Philip L. De Jager32,
  50. Masashi Fujita32,
  51. Vaishnavi Jadhav6,33,
  52. Bruce T. Lamb3,6,33,
  53. Andy P. Tsai33,34,
  54. Isabel Castanho35,36,
  55. Jonathan Mill35,
  56. Michael W. Weiner37,38,
  57. the Alzheimer’s Disease Neuroimaging Initiative (ADNI)§,
  58. the Alzheimer’s Disease Neuroimaging Initiative – Department of Defense§,
  59. the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Study (A4 Study)§,
  60. the Australian Imaging, Biomarker & Lifestyle Study (AIBL)§ and
  61. Andrew J. Saykin1,2,3,5,6,¥
  1. 1Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA
  2. 2Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN, USA
  3. 3Indiana Alzheimer’s Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA
  4. 4Department of BioHealth Informatics, Indiana University-Purdue University, Indianapolis, IN, USA
  5. 5Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
  6. 6Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA
  7. 7National Centralized Repository for Alzheimer’s Disease and Related Dementias, Indiana University School of Medicine, Indianapolis, IN, USA
  8. 8Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN, USA
  9. 9Department of Neurology, Keck School of Medicine, University of Southern California, San Diego, CA, USA
  10. 10Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
  11. 11Eli Lilly and Company, Indianapolis, IN, USA
  12. 12Department of Radiology, Mayo Clinic, Rochester, MN, USA
  13. 13UC Berkeley Helen Wills Neuroscience Institute, University of California - Berkeley, Berkeley, CA, USA
  14. 14Genomics Research Center, AbbVie, North Chicago, Illinois, USA
  15. 15CSIRO Health and Biosecurity, Melbourne, Australia
  16. 16Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, VIC, Australia
  17. 17Centre for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia
  18. 18Florey Institute of Neuroscience and Mental Health and The University of Melbourne, Parkville, VIC, Australia
  19. 19Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  20. 20Vanderbilt Memory & Alzheimer’s Center, Vanderbilt University Medical Center, Nashville, TN, USA
  21. 21Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA
  22. 22Department of Neurology & Neurological Sciences, Stanford University, Stanford, CA, USA
  23. 23Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
  24. 24Center for Alzheimer’s Research and Treatment, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  25. 25Department of Neurology, Mayo Clinic, Rochester, MN, USA
  26. 26Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA, USA
  27. 27Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
  28. 28Department of Neurological Sciences, Rush Medical College, Rush University, Chicago, IL, USA
  29. 29Department of Psychiatry, Washington University, St. Louis, MO, USA
  30. 30Department of Radiology, Washington University School of Medicine, St. Louis, MO, USA
  31. 31NeuroGenomics and Informatics Center, Washington University School of Medicine, St. Louis, MO, USA
  32. 32Center for Translational and Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, USA
  33. 33Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA
  34. 34Wu Tsai Neurosciences Institute, Stanford University School of Medicine, Stanford, CA, USA
  35. 35Department for Clinical and Biomedical Sciences, University of Exeter Medical School, University of Exeter, UK
  36. 36Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA Harvard Medical School, Boston, MA, USA
  37. 37Departments of Radiology, Medicine, and Psychiatry, University of California-San Francisco, San Francisco, CA, USA
  38. 38Department of Veterans Affairs Medical Center, San Francisco, CA, USA
  1. ↵¥Please address correspondence to: Andrew J. Saykin, PsyD, Department of Radiology and Imaging Sciences, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA, Phone: 317-278-6947; Fax. 317-274-1067; E-mail: asaykin{at}iu.edu

  1. ↵* These authors contributed equally to this work.

Back to top
Posted March 01, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Novel CYP1B1-RMDN2 Alzheimer’s disease locus identified by genome-wide association analysis of cerebral tau deposition on PET
Kwangsik Nho, Shannon L. Risacher, Liana Apostolova, Paula J. Bice, Jared Brosch, Rachael Deardorff, Kelley Faber, Martin R. Farlow, Tatiana Foroud, Sujuan Gao, Thea Rosewood, Jun Pyo Kim, Kelly Nudelman, Paul Aisen, Reisa Sperling, Basavaraj Hooli, Sergey Shcherbinin, Diana Svaldi, Clifford R. Jack, William J. Jagust, Susan Landau, Aparna Vasanthakumar, Jeffrey F. Waring, Vincent Doré, Simon M. Laws, Colin L. Masters, Tenielle Porter, Christopher C. Rowe, Victor L Villemagne, Logan Dumitrescu, Timothy J. Hohman, Julia B. Libby, Elizabeth Mormino, Rachel F. Buckley, Keith Johnson, Hyun-Sik Yang, Ronald C. Petersen, Vijay K. Ramanan, Prashanthi Vemuri, Ann D. Cohen, Kang-Hsien Fan, M. Ilyas Kamboh, Oscar L. Lopez, David A. Bennett, Muhammad Ali, Tammie Benzinger, Carlos Cruchaga, Diana Hobbs, Philip L. De Jager, Masashi Fujita, Vaishnavi Jadhav, Bruce T. Lamb, Andy P. Tsai, Isabel Castanho, Jonathan Mill, Michael W. Weiner, the Alzheimer’s Disease Neuroimaging Initiative (ADNI), the Alzheimer’s Disease Neuroimaging Initiative – Department of Defense, the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Study (A4 Study), the Australian Imaging, Biomarker & Lifestyle Study (AIBL), Andrew J. Saykin
medRxiv 2023.02.27.23286048; doi: https://doi.org/10.1101/2023.02.27.23286048
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area